Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlobeImmune Inc (NASDAQ:GBIM)

2.20
Delayed Data
As of Jul 31
 +0.05 / +2.33%
Today’s Change
2.03
Today|||52-Week Range
11.16
-71.01%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close2.15
Today’s open2.15
Day’s range-- - --
Volume7,739
Average volume (3 months)55,705
Market cap$12.7M
Dividend yield--
Data as of 07/31/2015

Growth & Valuation

Earnings growth (last year)-572.52%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-73.50%
P/E ratioNM
Price/Sales3.71
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
APPYVenaxis Inc+0.02+4.07%
GBSNGreat Basin Scientif...+0.08+2.95%
GALTUGalectin Therapeutic...0.000.00%
INISInternational Isotop...+0.00+1.09%
Data as of 3:08pm ET, 07/31/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.0M
Annual profit (last year)-$16.3M
Net profit margin-272.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts